₹484.90
−2.78%NSE close, 16 Nov 2026
+5.39%
Unichem Laboratories is a small cap company, listed on NSE under the symbol UNICHEMLAB. At ₹484.90 a share, the market values the whole company at ₹3,414 crore.
In FY26, it reported sales of ₹2,202 crore and a net profit of ₹253 crore, an operating margin of 8.4%. Over the last three years, sales grew 17.9% a year.
The market values the company at 10.1 times its profit over the last twelve months and 1.23 times its book value; its return on equity is 12.2% and its borrowings are 0.17 times its equity.
Promoters hold 70.22% of the shares. Foreign institutions hold 2.70%, and domestic institutions, mutual funds among them, 9.40%.
Over the past year the share price has risen 3.2%, and it is 29.4% below its 52-week high.
₹ crore. Consolidated figures.
The financial results for the period ended September 30, 2026.
USFDA Inspection At Goa Formulation Facility
Extension Of The Exercise Period For The Options Granted And Vested Under Unichem Employee Stock Option Scheme 2018
| Mar 2026 |
|---|
| Jun 2026 |
|---|
| Sep 2026 |
|---|
| Sales | 434 | 432 | 446 | 462 | 533 | 587 | 527 | 579 | 521 | 575 | 633 | 640 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Expenses | 396 | 406 | 403 | 405 | 448 | 503 | 504 | 513 | 476 | 527 | 563 | 566 |
| Operating profit | 38.1 | 25.4 | 43.5 | 57.5 | 85.5 | 83.7 | 22.5 | 66.2 | 44.8 | 47.7 | 69.9 | 74.5 |
| Operating margin | 8.8% | 5.9% | 9.7% | 12.4% | 16.0% | 14.3% | 4.3% | 11.4% | 8.6% | 8.3% | 11.1% | 11.6% |
| Other income | 11.3 | 6.2 | 3.9 | 8.8 | 13.6 | 9.3 | 6.8 | 21.0 | 11.8 | 23.5 | 15.6 | 15.4 |
| Interest | 5.6 | 4.6 | 4.0 | 4.8 | 6.8 | 5.5 | 6.5 | 8.2 | 7.4 | 9.4 | 6.6 | 7.7 |
| Depreciation | 27.9 | 27.2 | 28.3 | 28.5 | 30.5 | 29.7 | 31.8 | 31.5 | 31.3 | 30.6 | 29.9 | 30.5 |
| Profit before tax | 84.0 | −126 | 15.0 | 33.0 | 61.9 | 57.8 | −9.0 | −10.8 | 293 | 18.8 | 49.0 | 27.4 |
| Tax | −0.0 | 3.4 | 5.7 | 2.5 | 4.0 | 4.8 | 1.5 | 1.1 | 29.1 | 7.9 | 7.5 | 5.2 |
| Net profit | 84.0 | −129 | 9.3 | 30.5 | 57.9 | 53.0 | −10.5 | −11.9 | 264 | 10.9 | 41.5 | 22.2 |
| EPS (₹) | 11.93 | -18.37 | 1.31 | 4.34 | 8.22 | 7.52 | -1.49 | -1.69 | 37.54 | 1.55 | 6.61 | 3.16 |
₹ crore, financial years to March.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,211 | 1,235 | 1,270 | 1,343 | 1,705 | 2,111 | 2,202 |
| Expenses | 1,264 | 1,261 | 1,144 | 1,197 | 1,389 | 1,605 | 1,846 | 2,018 |
| Operating profit | −83.5 | −50.8 | 91.1 | 72.8 | −45.6 | 100 | 265 | 184 |
| Operating margin | -7.1% | -4.2% | 7.4% | 5.7% | -3.4% | 5.9% | 12.5% | 8.4% |
| Other income | 98.4 | 91.3 | 50.2 | 47.5 | 38.5 | 31.6 | 35.3 | 63.1 |
| Interest | 7.5 | 7.9 | 5.1 | 6.1 | 17.3 | 22.7 | 21.0 | 31.6 |
| Depreciation | 67.4 | 81.7 | 84.4 | 91.2 | 113 | 113 | 125 | 125 |
| Profit before tax | −60.0 | −49.0 | 51.8 | 23.0 | −176 | −61.7 | 155 | 292 |
| Tax | −34.4 | 12.0 | 17.2 | −11.1 | 25.9 | 8.8 | 17.1 | 39.5 |
| Net profit | −23.8 | −60.2 | 34.3 | 33.1 | −202 | −70.5 | 138 | 253 |
| EPS (₹) | -3.38 | -8.55 | 4.88 | 4.70 | -28.72 | -10.01 | 19.53 | 35.91 |
₹ crore, at each year's end and the latest half year.
| Line | FY23 | FY24 | FY25 | FY26 | Sep 2026 |
|---|---|---|---|---|---|
| Shareholders’ equity | 2,435 | 2,362 | 2,451 | 2,717 | 2,781 |
| Borrowings | 297 | 219 | 430 | 469 | 475 |
| Total liabilities | 758 | 807 | 1,119 | 1,020 | 1,126 |
| Fixed assets | 1,255 | 1,194 | 1,279 | 1,204 | 1,163 |
| Investments | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash and equivalents | 184 | 151 | 89.6 | 289 | 157 |
| Total assets | 3,193 | 3,169 | 3,569 | 3,737 | 3,908 |
₹ crore, by financial year, and the latest half year.
| Line | FY22 | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|---|
| From operations | −260 | −7.0 | 3.6 | −68.1 |
| From investing | 100 | −241 | 192 | −51.7 |
| From financing | 191 | 184 | 1.9 | −11.2 |
| Spent on fixed assets | −127 | −137 | −123 | −55.2 |
| Free cash flow | −387 | −144 | −119 | −123 |
Margins, returns, debt, tax and cash.
| Line | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Net margin | -2.0% | -5.0% | 2.8% | 2.6% | -15.1% | -4.1% | 6.5% | 11.5% |
| Operating margin | -7.1% | -4.2% | 7.4% | 5.7% | -3.4% | 5.9% | 12.5% | 8.4% |
| Return on equity | – | – | – | – | -8.3% | -3.0% | 5.6% | 9.3% |
| Return on capital employed | – | – | – | – | -5.8% | -1.5% | 6.1% | 10.2% |
| Return on assets | – | – | – | – | -6.3% | -2.2% | 3.9% | 6.8% |
| Debt to equity | – | – | – | – | 0.12 | 0.09 | 0.18 | 0.17 |
| Interest coverage | -7.00 | -5.20 | 11.10 | 4.80 | -9.20 | -1.70 | 8.40 | 10.30 |
| Debt to assets | – | – | – | – | 0.09 | 0.07 | 0.12 | 0.13 |
| Current ratio | – | – | – | – | 2.48 | 2.39 | 2.05 | 2.48 |
| Quick ratio | – | – | – | – | 1.51 | 1.40 | 1.05 | 1.38 |
| Cash ratio | – | – | – | – | 0.29 | 0.21 | 0.09 | 0.33 |
| Asset turnover | – | – | – | – | 0.42 | 0.54 | 0.59 | 0.59 |
| Fixed asset turnover | – | – | – | – | 1.07 | 1.43 | 1.65 | 1.83 |
| Inventory turnover | – | – | – | – | – | 0.90 | 0.90 | 1.00 |
| Receivables turnover | – | – | – | – | 2.30 | 2.80 | 2.70 | 2.70 |
| Gross margin | – | – | – | – | – | 61.0% | 59.1% | 53.7% |
| Cash from operations to profit | – | – | – | -785.0% | – | – | -5.0% | 1.0% |
| Effective tax rate | – | – | 33.1% | – | – | – | 11.0% | 13.5% |
Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had…
Significant increase in volume has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has…
A copy Srutinizers report of undefined held on August 11, 2026. Further, the company has informed the Exchange regarding voting results.
Proceedings of Annual General Meeting held on August 11, 2026
The financial results for the period ended Jun 30, 2026.
A copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Significant movement in price has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written…
Significant movement in price has been observed in Unichem Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written…
.
Notice of Annual General Meeting to be held on August 11, 2026